Buy Piramal Pharma, target price Rs 180: ICICI Securities

Piramal Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Other Operating Revenue for the year ending 31-Mar-2023.

By ETMarkets.com | Updated: Apr 16, 2024, 09.41 AM IST

Promoters held 35.02 per cent stake in the company as of 31-Dec-2023, while FIIs owned 32.51 per cent, DIIs 9.68 per cent.

ICICI Securities has buy call on Piramal Pharma with a target price of Rs 180. The current market price of Piramal Pharma Ltd. is Rs 141.5.

Piramal Pharma Ltd., incorporated in the year 2020, is a Small Cap company (having a market cap of Rs 18627.11 Crore) operating in Pharmaceuticals sector.

Piramal Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Other Operating Revenue for the year ending 31-Mar-2023.

Financials
For the quarter ended 31-12-2023, the company reported a Consolidated Total Income of Rs 2020.08 Crore, up 3.04 % from last quarter Total Income of Rs 1960.57 Crore and up 12.32 % from last year same quarter Total Income of Rs 1798.51 Crore. Company reported net profit after tax of Rs -3.84 Crore in latest quarter.

Promoter/FII Holdings
Promoters held 35.02 per cent stake in the company as of 31-Dec-2023, while FIIs owned 32.51 per cent, DIIs 9.68 per cent.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!